Your search returned 6 results.

Results
	1.	Effects of lorcaserin on pre-existing valvulopathy: A pooled analysis of phase 3 trials. MedStar authors: Weissman, Neil J PMID: 27888609 Year: 2017 Citation: Obesity. 25(1):39-44, 2017 Jan Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Fain R, Hall N, Shanahan WR, Smith SR, Weissman NJ DOI: https://dx.doi.org/10.1002/oby.21695 Add to cart (remove)
	2.	Mifepristone Improves Adipose Tissue Insulin Sensitivity in Insulin Resistant Individuals. MedStar authors: Sharma, Susmeeta PMID: 33507248 Year: 2021 Citation: Journal of Clinical Endocrinology & Metabolism. 106(5):1501-1515, 2021 04 23. Institution: MedStar Washington Hospital Center Department: Medicine/Endocrinology Medline publication type: Journal Article Form of publication: Journal Article All authors: Grewal S, Gubbi S, McGlotten R, Muniyappa R, Nieman LK, Sharma ST DOI: https://dx.doi.org/10.1210/clinem/dgab046 Add to cart (remove)
	3.	Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients. MedStar authors: Weissman, Neil J PMID: 30145941 Year: 2018 Citation: New England Journal of Medicine. 379(12):1107-1117, 2018 09 20. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Bohula EA, Bonaca MP, Brown C, Budaj A, CAMELLIA-TIMI 61 Steering Committee and Investigators, Dhadda S, Fanola CL, Francis B, Garcia-Castillo A, Gupta M, Im K, Inzucchi SE, Keech AC, Kuder J, Leiter LA, McGuire DK, Miao W, Patel T, Perdomo C, Qamar A, Ruff CT, Sabatine MS, Scirica BM, Smith SR, Weissman NJ, White HD, Wiviott SD DOI: https://dx.doi.org/10.1056/NEJMoa1808721 Add to cart (remove)
	4.	Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study. MedStar authors: Weissman, Neil J PMID: 22421927 Year: 2012 Citation: Obesity. 20(7):1426-36, 2012 Jul. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Randomized Controlled Trial Form of publication: Journal Article All authors: Anderson CM, Fidler MC, O'Neil PM, Raether B, Sanchez M, Shanahan WR, Smith SR, Weissman NJ, Zhang J DOI: http://dx.doi.org/10.1038/oby.2012.66 Add to cart (remove)
	5.	Echocardiographic assessment of cardiac valvular regurgitation with lorcaserin from analysis of 3 phase 3 clinical trials. MedStar authors: Weissman, Neil J PMID: 23661689 Year: 2013 Citation: Circulation. Cardiovascular imaging. 6(4):560-7, 2013 Jul. Institution: MedStar Heart & Vascular Institute Medline publication type: Clinical Trial, Phase III Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Anderson CM, Koch GG, Sanchez M, Shanahan WR, Smith SR, Weissman NJ DOI: http://dx.doi.org/10.1161/CIRCIMAGING.112.000128 Add to cart (remove)
	6.	Neuropsychiatric safety with liraglutide 3.0mg for weight management: results from randomized controlled phase 2 and 3a trials. MedStar authors: Aroda, Vanita R PMID: 28386912 Year: 2017 Citation: Diabetes, Obesity & Metabolism. 19(11):1529-1536, 2017 Nov. Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Aroda VR, Astrup A, Brett J, Cancino A, Kushner R, Lau DC, O'Neil PM, Satiety and Clinical Adiposity - Liraglutide Evidence in individuals with and without diabetes (SCALE) study groups, Wadden TA, Wilding JP DOI: https://dx.doi.org/10.1111/dom.12963 Add to cart (remove)

Powered by Koha